Effects of Ruangan Huajian granul on Expression of VEGF and TGF-β_1 in Liver Fiberosis
Zhao Yanlong
Abstract
Zhao Yanlong
Abstract
【Objective】To investigate the effect of ruangan huajian granul on expression of VEGF and TGF-β1 in liver fiberosis.【Methods】Sixty male adult SD rats were randomLy divided into three groups(n=20 each),control group(A group),acute CCL4hepatic injury model group(B group),ruangan huajian granul(C group).SD rats with exprimental hepatic fibrosis were induced by intraperitoneal injection of l0%CC14,8weeks after modeling,the intervention group by ruangan huajian granuls,The expression of VEGF and TGF-β1 were evaluated after 6weeks.【Results】After treatment,the expression of VEGF and TGF-β1 of B group was higer significantly difference with C group(P0.05).【Conclusion】Ruangan huajian granul may alleviate liver fiberosis in rats,it was possibly through decreasing the expression of VEGF and TGF-β1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
【Objective】To investigate the effect of ruangan huajian granul on expression of VEGF and TGF-β1 in liver fiberosis.【Methods】Sixty male adult SD rats were randomLy divided into three groups(n=20 each),control group(A group),acute CCL4hepatic injury model group(B group),ruangan huajian granul(C group).SD rats with exprimental hepatic fibrosis were induced by intraperitoneal injection of l0%CC14,8weeks after modeling,the intervention group by ruangan huajian granuls,The expression of VEGF and TGF-β1 were evaluated after 6weeks.【Results】After treatment,the expression of VEGF and TGF-β1 of B group was higer significantly difference with C group(P0.05).【Conclusion】Ruangan huajian granul may alleviate liver fiberosis in rats,it was possibly through decreasing the expression of VEGF and TGF-β1.
Key concepts: Medicine, Intraperitoneal injection, Transforming growth factor, Internal medicine, Vascular endothelial growth factor, Endocrinology, VEGF receptors